Development and Verification of an Immune-Based Gene Signature for Risk Stratification and Immunotherapeutic Efficacy Assessment in Gastric Cancer
Objective. Due to the molecular heterogeneity of gastric cancer, only minor patients respond to immunotherapeutic schemes. This study is aimed at developing an immune-based gene signature for risk stratification and immunotherapeutic efficacy assessment in gastric cancer. Methods. An immune-based ge...
Guardado en:
Autores principales: | Feng Qiu, Yumei Zhu, Yafeng Shi, Jingjing Ji, Yingchao Jin |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Hindawi Limited
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/909b07ac07744e1bb3896875db260a51 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Novel Immunotherapeutic Approach in Gastric Cancer
por: Gulubova M., et al.
Publicado: (2020) -
Immune Infiltration-Related Signature Predicts Risk Stratification and Immunotherapy Efficacy in Grade II and III Gliomas
por: Cong Luo, et al.
Publicado: (2021) -
A four-gene signature predicts survival and anti-CTLA4 immunotherapeutic responses based on immune classification of melanoma
por: Ying Mei, et al.
Publicado: (2021) -
Development and Verification of the Amino Metabolism-Related and Immune-Associated Prognosis Signature in Gliomas
por: Yang Xu, et al.
Publicado: (2021) -
Pan-Cancer Analysis Reveals the Signature of TMC Family of Genes as a Promising Biomarker for Prognosis and Immunotherapeutic Response
por: Jing Song, et al.
Publicado: (2021)